Lumotive and Gpixel Demonstrate Innovative Lidar Reference Design to Enable Faster Adoption of Next-Generation 3D Sensors
January 31, 2023 10:00 ET
|
Lumotive
SAN FRANCISCO, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Lumotive, the developer of Light Control Metasurface (LCM™) beam steering chips enabling the next generation of 3D sensors, and Gpixel, a leading...
Lumotive and Lumentum Introduce Innovative Reference Design to Enable Faster Adoption of Next-Generation 3D LiDAR Solutions
January 30, 2023 10:00 ET
|
Lumotive
SEATTLE and SAN JOSE, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Lumotive, the developer of Light Control Metasurface (LCM™) beam steering chips enabling the next generation of 3D sensors, and Lumentum...
Telerehabilitation Market Predicted to Reach USD 12.9 Billion by 2031, Says Allied Market Research
November 17, 2022 05:00 ET
|
Allied Market Research
Portland, OR, Nov. 17, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global telerehabilitation market generated $3.7 billion in 2021, and is projected to...
Aeterna Zentaris Reports Second Quarter 2022 Financial Results and Recent Highlights
August 03, 2022 17:30 ET
|
Aeterna Zentaris Inc
– Company ended the quarter with $58.2 million in cash – Driving continued progress across diversified pre-clinical and clinical development pipeline TORONTO, ONTARIO, Aug. 03, 2022 (GLOBE...
atai Life Sciences legt Finanzergebnisse für das zweite Quartal 2021 und Unternehmens-Update vor
August 17, 2021 15:57 ET
|
Atai Life Sciences
- Erfolgreicher Nasdaq-Börsengang mit erzieltem Bruttoerlös von 258,8 Millionen US-Dollar, einschließlich Überzuteilung des Unterzeichners - Erhalt von Vorauszahlung von Otsuka in Höhe 20 Millionen...
atai Life Sciences Reports Second Quarter 2021 Financial Results and Business Update
August 16, 2021 07:00 ET
|
atai Life Sciences
-Successfully completed Initial Public Offering on Nasdaq raising $258.8 million in gross proceeds, including the underwriters’ over-allotment- -Received $20 million upfront payment from Otsuka as...
atai Life Sciences gründet in Partnerschaft mit der University of Queensland InnarisBio mit dem Ziel, eine wirksamere nasale Verabreichungsmethode für atais Plattform therapeutischer Programme für mentale Gesundheit zu entwickeln
July 29, 2021 09:19 ET
|
Atai Life Sciences
BERLIN und BRISBANE, Australien, July 29, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences(„atai“ oder das „Unternehmen“) (Nasdaq: ATAI), ein biopharmazeutisches Unternehmen im klinischen Stadium, das...
atai Life Sciences launches InnarisBio, in partnership with the University of Queensland, with the aim to develop a more effective nose-to-brain delivery method for atai’s platform of mental health therapeutic programs
July 28, 2021 09:12 ET
|
atai Life Sciences
BERLIN and BRISBANE, Australia, July 28, 2021 (GLOBE NEWSWIRE) -- atai Life Sciences (“atai” or the “Company”) (Nasdaq: ATAI), a clinical-stage biopharmaceutical company aiming to transform the...
LifeSignals Launches Life Signal(TM) Processor Product Family, Developed with Support of 3M and STMicroelectronics
May 09, 2018 10:00 ET
|
STMicroelectronics N.V.
A new class of wireless biosensor platform purpose-built for OEMs to create wearables for life-critical medical and healthcare monitoring applications LifeSignals worked with 3M and...
PreveCeutical Announces Incorporation of Australian Subsidiary to Support Ongoing Research Programs
March 16, 2018 09:00 ET
|
PreveCeutical Medical Inc.
VANCOUVER, British Columbia, March 16, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces the...